SCHEMBL19079787

SCHEMBL19079787

Cn1c(SCC(=O)c2ccc(F)cc2)nc2sc3c(c2c1=O)CCCC3

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.62
▸ PDE4D Q08499 3/20 0.61
▸ TP53 P04637 2/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ CREBBP Q92793 1/20 0.61
▸ MAPT P10636 3/20 0.60
▸ ALDH1A1 P00352 3/20 0.57
▸ USP2 O75604 2/20 0.56
▸ TSHR P16473 1/20 0.56
▸ NPY1R P25929 1/20 0.56
▸ NPY2R P49146 1/20 0.56
▸ POLB P06746 1/20 0.56
▸ GRK2 P25098 1/20 0.56
▸ CTDSP1 Q9GZU7 1/20 0.56
▸ KDM4E B2RXH2 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ LMNA P02545 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079779 0.86 RXFP1 (0.84) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL19079778 0.84 RXFP1 (0.64) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL24169178 0.79 RXFP1 (0.81) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL19079783 0.79 PDE4D (0.80) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL22533334 0.78 SMN1; SMN2 (0.71) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL19079736 0.78 PDE4D (0.68) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL19079785 0.77 RXFP1 (0.78) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL19079693 0.77 PDE4D (0.57) RXFP1PDE4DTP53SMN1; SMN2CREBBP
SCHEMBL19079784 0.77 POLB (0.71) RXFP1PDE4DTP53SMN1; SMN2MAPT
SCHEMBL19088672 0.77 RXFP1 (0.85) RXFP1PDE4DTP53SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A RXFP1 381/4885PDE4D 6/4885TP53 4300/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A RXFP1 381/4885PDE4D 6/4885TP53 4300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback